ERBB2 mRNA expression was detected by the APIS BC Subtyping Kit in a subset of patients with 0 and 1+ IHC HER2 scores, highlighting the continuous nature of ERBB2 expression, and providing an opportunity to enhance HER2 stratification into a HER2-low category. The gene discussed is ERBB2; the disease is breast cancer.